APRAMEYA Aprameya Enginee Q4 FY25 results (Jan–Mar 2025) and concall
Aprameya Engineering Limited reported robust financial performance for FY25, with significant year-on-year growth in revenue, EBITDA, and PAT, driven by a strategic shift towards high-margin turnkey projects. The company is actively expanding its geographical footprint and innovating with proprietary healthcare solutions, while also focusing on improving working capital management and reducing debtor days to enhance cash flow.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q4 FY25 |
|---|---|---|
| Revenue | 9 | 126 |
| EBITDA | -1 | 26 |
| Net profit | -2 | 18 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
